Literature DB >> 2268988

Influence of age on the pharmacokinetics of alfentanil. Gender dependence.

H J Lemmens1, A G Burm, P J Hennis, M P Gladines, J G Bovill.   

Abstract

Studies on the effects of age on the pharmacokinetics of alfentanil are inconclusive. A possible factor in explaining the differences between various studies could be the effect of gender. The authors studied the effects of age on the pharmacokinetics of alfentanil in female (n = 21) and male (n = 15) patients undergoing lower abdominal surgery under nitrous oxide alfentanil anaesthesia. There was a significant negative correlation (r = -0.79, p less than 0.001) between plasma alfentanil clearance (CL) and age in women (less than 50y, median CL 24.84 L/h; greater than 50y, median CL 14.52 L/h), but not in men (less than 50y, median CL 19.44 L/h; greater than 50y, median CL 16.2 L/h). The conclusion is drawn that the effects of age on the pharmacokinetics of alfentanil are gender-dependent.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2268988     DOI: 10.2165/00003088-199019050-00005

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


  12 in total

1.  Commentary: a physiological approach to hepatic drug clearance.

Authors:  G R Wilkinson; D G Shand
Journal:  Clin Pharmacol Ther       Date:  1975-10       Impact factor: 6.875

2.  Population pharmacokinetics of alfentanil: the average dose-plasma concentration relationship and interindividual variability in patients.

Authors:  P O Maitre; S Vozeh; J Heykants; D A Thomson; D R Stanski
Journal:  Anesthesiology       Date:  1987-01       Impact factor: 7.892

3.  Inhibition of alfentanil metabolism by erythromycin.

Authors:  R R Bartkowski; M E Goldberg; G E Larijani; T Boerner
Journal:  Clin Pharmacol Ther       Date:  1989-07       Impact factor: 6.875

4.  Decreased fentanyl and alfentanil dose requirements with age. A simultaneous pharmacokinetic and pharmacodynamic evaluation.

Authors:  J C Scott; D R Stanski
Journal:  J Pharmacol Exp Ther       Date:  1987-01       Impact factor: 4.030

5.  The pharmacokinetics of alfentanil (R39209): a new opioid analgesic.

Authors:  J G Bovill; P S Sebel; C L Blackburn; J Heykants
Journal:  Anesthesiology       Date:  1982-12       Impact factor: 7.892

6.  Alfentanil kinetics in the elderly.

Authors:  H Helmers; A Van Peer; R Woestenborghs; H Noorduin; J Heykants
Journal:  Clin Pharmacol Ther       Date:  1984-08       Impact factor: 6.875

7.  Comparison of a computer-assisted infusion versus intermittent bolus administration of alfentanil as a supplement to nitrous oxide for lower abdominal surgery.

Authors:  M E Ausems; J Vuyk; C C Hug; D R Stanski
Journal:  Anesthesiology       Date:  1988-06       Impact factor: 7.892

8.  Diazepam disposition determinants.

Authors:  D J Greenblatt; M D Allen; J S Harmatz; R I Shader
Journal:  Clin Pharmacol Ther       Date:  1980-03       Impact factor: 6.875

Review 9.  Clinical pharmacokinetics of fentanyl and its newer derivatives.

Authors:  L E Mather
Journal:  Clin Pharmacokinet       Date:  1983 Sep-Oct       Impact factor: 6.447

10.  Effect of age, gender, and obesity on midazolam kinetics.

Authors:  D J Greenblatt; D R Abernethy; A Locniskar; J S Harmatz; R A Limjuco; R I Shader
Journal:  Anesthesiology       Date:  1984-07       Impact factor: 7.892

View more
  8 in total

1.  Prediction of cytochrome p450-mediated hepatic drug clearance in neonates, infants and children : how accurate are available scaling methods?

Authors:  Sven Björkman
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

2.  Sex, age and alfentanil pharmacokinetics.

Authors:  A Rubio; C Cox
Journal:  Clin Pharmacokinet       Date:  1991-07       Impact factor: 6.447

Review 3.  The influence of age and sex on the clearance of cytochrome P450 3A substrates.

Authors:  Monette M Cotreau; Lisa L von Moltke; David J Greenblatt
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

Review 4.  Age-related changes in hepatic function. Implications for drug therapy.

Authors:  K Woodhouse; H A Wynne
Journal:  Drugs Aging       Date:  1992 May-Jun       Impact factor: 3.923

Review 5.  Drug dosage in the elderly. Is it rational?

Authors:  K Turnheim
Journal:  Drugs Aging       Date:  1998-11       Impact factor: 3.923

Review 6.  Gender differences in pharmacokinetics.

Authors:  C H Gleiter; U Gundert-Remy
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1996 Apr-Jun       Impact factor: 2.441

Review 7.  Gender effects in pharmacokinetics and pharmacodynamics.

Authors:  R Z Harris; L Z Benet; J B Schwartz
Journal:  Drugs       Date:  1995-08       Impact factor: 9.546

8.  The distribution and gender difference of CYP3A activity in Chinese subjects.

Authors:  Bing Zhu; Zhao-Qian Liu; Guo-Lin Chen; Xiao-Ping Chen; Dong-Sheng Ou-Yang; Lian-Sheng Wang; Song-Lin Huang; Zhi-Rong Tan; Hong-Hao Zhou
Journal:  Br J Clin Pharmacol       Date:  2003-03       Impact factor: 4.335

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.